"Beneficial discussion of specific screening tools and standardized tests; how to communicate test results to your client; differences between HOA, MCI, Dementia." M.H. (Dec. 2024)

"Topics pertaining to specific screening and diagnostic instruments available were beneficial." L.B. (Nov. 2024)

"I enjoyed learning about the various quick tests and screening tools as well as the standardized tests that one can utilize for assessing mild cognitive impairment. Easy to access and view at my own pace." H.B. (Nov. 2024)

"The different tests were beneficial. This course was challenging, but presented in a clear and concise way." T.M. (Oct. 2024)

"Great overview to deepen my knowledge." E.H. (Aug. 2024)

"All of the information was helpful. I liked the online convenience." J.H. (Jul. 2024)

"Differences between healthy aging and MCI was helpful. I liked the assessment areas." C.C. (Jul. 2024)

"The topics related to PD, LBD, and FTD were beneficial. Good refresher on neurocognitive disorders and MCI." A.V. (Jun. 2024)

"Discussing which tests to use for assessment was helpful. I enjoyed the knowledge of the presenters." S.E. (Jun. 2024)

"I work in LTC, so cognitive assessment was beneficial to discuss. The speaker used good slides." R.C. (May. 2024)

"Differentiating types of dementia and options for better screening were beneficial. Course was detailed." A.D. (Mar. 2024)

"Knowing when to refer to a physician was helpful to discuss. The course was presented in an orderly fashion." B.M. (Feb. 2024)

"Discussing types of MCI was beneficial. I liked the differentiation between normal aging and MCI." E.A. (Jan. 2024)

"Remembering to test multiple domains and multiple tests for each cognitive domain. Good overview without going into more detail than necessary for neuroanatomy, etc." M.W. (Dec. 2023)

"It was beneficial to discuss normal aging deficits compared to MCI. I liked the clarity of info provided." P.T. (Nov. 2023)

"The new test available for evals was helpful." C.O. (Nov. 2023)

"Discussing the differentiation between various diseases was helpful. I enjoyed the evaluations for MCI." R.J. (Nov. 2023)

"Excellent material presented. Screening measurements, the GADL, the difference between PD and LBD, and differentiation between 4 types of MCI were all beneficial." L.M. (Nov. 2023)

"This presentation was clear and precise. Discussing ways to access individuals at risk for MCI was beneficial." L.W. (Oct. 2023)

"Thorough explanation of MCI and dementia, including the different etiologies/types of dementia and differential diagnosis based on behaviors. I think the section on assessment was the most helpful for my practice." C.C. (Oct. 2023)

"I found this entire course beneficial to my knowledge base and daily practice. I really felt like the instructors were leaders in their field. It felt like I just took a mini college course. This might be the most informative course I have ever taken from Northern Speech." L.G. (Oct. 2023)

"I learned more about general aging versus MCI for my use in the community. I liked the way this course was broken down by units." S.S. (Oct. 2023)

"Easy to follow course. I liked the testing examples." K.C. (Oct. 2023)

"Course flowed easily with important content. Learning disorders and MCI characteristics was beneficial." D.K. (Sep. 2023)

"Efficient presentation with useful information. Test selection and predictive factors were beneficial. I liked the inclusion of benefits of various tests." S.K. (Aug. 2023)

"Different domains to address during an assessment. This course was well organized, and the presenter spoke clearly, slowly." S.Q. (Aug. 2023)

"Learning the tests available, and the differential diagnosis was beneficial." R.R. (Aug. 2023)

"I liked the various testing options and the information on the types of MCI and dementia." J.K. (Apr. 2023)

"Excellent, thorough, and well-presented review of types of MCI, which is a term at times misused in the profession. Clarification of the types of MCI and characteristics of PD and Lewy Body dementias was beneficial." S.C. (Feb. 2023)

"Excellent coverage of things we can address as SLPs when working with patients with MCI. I liked the assessment measures." L.D. (Jan. 2023)

"I liked the differentiation between mild cognitive impairment and healthy aging. Learning the different types of MCI. I thought course was very thorough in terms of defining the different types of dementia and the effects on cognitive-communication skills for each type." S.L. (Jan. 2023)

"I liked the information regarding different types of dementia, MCI types." D.K. (Jan. 2023)

"Learning difference between Parkinson's and Lewy body. Very informative course." J.M. (Dec. 2022)

"Learning the impact of a severe TBI and how the brain is affected immediately is most beneficial to my daily practice. The overall topic of age and how it impacts the brain/neurological diseases was very interesting to learn." A.C. (Dec. 2022)

"The entire course was beneficial. It was well organized." P.D. (Nov. 2022)

"Being able to complete this on my own timeline was good." J.G. (Nov. 2022)

"Very practical information regarding evaluation for MCI and differentiating between other neuro-cognitive disorders such as AD, Lewy Body Dementia, etc." L.H. (Nov. 2022)

"I can use this information tomorrow at work." S.B. (Nov. 2022)

"I liked the specific standardized batteries to use for each situation and practical explanations." M.V. (Oct. 2022)

"Very informative about best tests. Included practical information about how to discuss results with patients." J.W. (Oct. 2022)

"I liked the methods recommended for a thorough assessment of cognitive function." J.W. (Oct. 2022)

"The pace of the course was good. I liked the discussion of assessments." J.F. (Oct. 2022)

"The course was well organized and very informative. Good explanation of the standardized tests and recommendations for use of specific tests." L.H. (Sept. 2022)

"I liked the course. It was short and specific." T.M. (Sept. 2022)

"I like the handouts provided for use later." P.M. (Aug. 2022)

"Excellent information in all areas. Good screening and assessment information." C.L. (Aug. 2022)

"The course is easy to follow." A.S. (Aug. 2022)

"The course format was excellent!"  K.H. (Jul. 2022)

"I liked the content – assessment, counseling, follow up, and treatment." C.B. (Jun. 2022)

"I liked the comprehensive nature of the presentation; the dividing of the subject matter into units; and the specific information regarding the identification of MCI." L.M. (Jun. 2022)

"The visuals were good, and learning to differentiate different forms of dementia vs. MCI was helpful." B.W. (May 2022)

"The organization of the material, and the presenter's knowledge of the subject made this course very interesting, and very worthwhile for SLPs." J.B. (Jan. 2022)

"Easy to access and can stop and replay to take notes." P.W. (Jan. 2022)

"Review of MCI types, dementia types, and standardized screening tools was helpful. I will share with professionals and use this in my clinical practice. All of the information was very good and important." A.H.

1. Describe mild cognitive impairment and the need for early identification.
2. Contrast mild cognitive impairment from healthy aging.
3. Contrast mild cognitive impairment from mild dementia.
4. Interpret the evidence-based guidelines for diagnosing mild cognitive impairment.
5. Summarize the characteristics of good screening tools and neuropsychological test batteries.
6. Identify language performance deficits that are early indicators of mild cognitive impairment.
7. Identify factors to consider in interpreting test performance.
8. Describe considerations when counseling clients and interpreting performance data.

This program is offered for 0.2 ASHA CEUs (Intermediate Level; Professional Area).

ASHA CEUs: NSS online courses are registered with ASHA and are offered for ASHA CEUs. The number of ASHA CEUs is noted above. Note that 0.1 ASHA CEU = 1 contact hour = equals 1 CEE.

ASHA CEUs: Attendees must meet at least one of the following conditions in order to be eligible to earn ASHA CEUs:

• Current ASHA Member
• ASHA Certificate of Clinical Competence (CCC) Holder
• Licensed by a state or provincial regulatory agency to practice speech-language pathology (SLP) or audiology
• Credentialed by a state regulatory agency to practice SLP or audiology
• Credentialed by a national regulatory agency to practice SLP or audiology
• Engaged in a Clinical Fellowship under the supervision of an individual with their ASHA CCC
• Currently enrolled in a master's or doctoral program in SLP or audiology

If an attendee is not an ASHA member or CCC holder but meets any of the above criteria, they may inform the ASHA CE Registry of their eligibility by visiting this site.